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We report the characterization of a novel reassortant influ-
enza A(H1N2) virus not previously reported in humans. Re-
covered from a a pig farm worker in southeast Brazil who 
had influenza-like illness, this virus is a triple reassortant 
containing gene segments from subtypes H1N2 (hemagglu-
tinin), H3N2 (neuraminidase), and pandemic H1N1 (remain-
ing genes).
Influenza A(H1N2) viruses have been described in hu-man, avian, and especially swine populations over many 
years (1,2). In contrast to the widespread circulation of sea-
sonal H1N1 and H3N2 viruses, subtype H1N2 has been ob-
served only sporadically in humans (1,3–7). Human H1N2 
infections were reported during 1988–89 from sporadic 
cases over the winter in China (3). In 2000, another H1N2 
subtype strain emerged in the human population and be-
came widespread in Europe, with sporadic cases reported 
in the Middle East, Asia, Africa, and the Americas dur-
ing 2001–2003 (1,4). In Brazil, this H1N2 subtype strain 
was detected in humans in the southeast region during the 
winter of 2002 and in the northern region at the beginning 
of 2003 (5). This 2000–2003 H1N2 subtype strain had a 
genetic origin similar to the 1988–1989 H1N2 strain from 
China, both reassortants between human seasonal H1N1 
and H3N2 subtype lineages (3,4). 
In contrast, sporadic cases of zoonotic human infec-
tions with swine-origin H1N2 subtype variants (H1N2v) 
have also been described (6,7). In Brazil, the passive moni-
toring of influenza A viruses in pigs has taken place since 
2009 (8). Recently, a phylogenetic study revealed that 
H1N2 subtype viruses have circulated undetected in swine 
herds in Brazil for more than a decade, and reassortments 
may have occurred (9). These viruses seem to be reas-
sortants originating from an ancestor virus introduced to 
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pigs from humans in the late 1990s and early 2000s and 
remained as a relic from a now-extinct human-host hemag-
glutinin lineage. However, after the emergence in humans 
of influenza A(H1N1)pdm09 in 2009, reassortment events 
lead to H1N2 viruses acquiring internal genes segments 
from the pandemic strain (9). 
Even though these H1N2 subtype strains from Brazil 
circulating in the swine population, they have not been de-
tected in humans. We report detection and characterization 
of a variant H1N2 subtype strain (H1N2v) with a genomic 
origin not previously reported in humans.
This virus was identified from a nasopharyngeal aspi-
rate collected on November 26, 2015, from a 16-year-old 
girl from a rural area in Castro City, Paraná, in the southern 
region of Brazil. Castro has ≈67,000 inhabitants and is a 
major livestock hub for dairy cattle, poultry, and pigs. The 
patient did not present any risk factors for influenza but 
showed development of an influenza-like illness with an 
onset of symptoms (fever, cough, sore throat, chest pain, 
and myalgia) on November 23, 2015. The follow-up local 
investigation reported that she had been working at a swine 
farm and confirmed direct patient contact with pigs. She 
had not received a prior influenza vaccine or antiviral treat-
ment, and her clinical recovery was uneventful. 
The virus sample was sent to the Central Laboratory of 
the State of Parana, where an influenza A virus strain was 
detected. This strain could not be further subtyped using 
the influenza real-time reverse transcription PCR protocol 
recommended by the World Health Organization. 
Genomic Sanger sequencing of the strain was con-
ducted at the National Influenza Center, IOC, FIOCRUZ, 
Rio de Janeiro, Brazil. BLAST (https://blast.ncbi.nlm.nih.
gov/Blast.cgi) was performed for each gene segment se-
quenced and revealed strong identity with an H1N2 virus 
subtype genome detected in swine in Santa Catarina, a state 
in southern Brazil, in 2011 (Table). The human viruses with 
closest identity to the H1N2v virus detected in this study 
were a 2003 H1N2 subtype human lineage (hemagglutinin 
gene), a 1998 H3N2 subtype human seasonal lineage (neur-
aminidase gene), and A(H1N1)pdm09 subtype lineage for 
all other genes. This virus isolate was designated as influ-
enza A/Parana/720/2015(H1N2v); the genome sequence is 
available in the GISAID database (http://platform.gisaid.
org; submission no. EPI_ISL_223342). 
We conducted phylogenetic reconstructions of each 
gene segment by the maximum-likelihood method us-
ing a dataset with all H1N2 subtype sequences and some 
representative sequences for H1N1 and H3N2 subtypes 
available in influenza genetic databases (online Techni-
cal Appendix, http://wwwnc.cdc.gov/EID/article/23/1/16-
1122-Techapp1.pdf). Our analysis revealed that each gene 
segment of A/Parana/720/2015(H1N2v) had the same phy-
logenetic profile as recent swine H1N2 subtype sequences 
from Brazil. This supports the BLAST findings and sug-
gests a recent swine–human infection by the H1N2v strain. 
Because similar swine strains have been identified in pigs 
≈300 km distant from where the human case occurred (9), 
the virus is likely to have been circulating in pigs in Castro 
City. The H1N2v subtype we report contained the S31N 
marker in the matrix 2 protein, which confers resistance to 
the adamantane antiviral class, similar to A(H1N1)pdm09 
viruses (10). 
To date, no further H1N2 subtype human cases have 
been detected in Brazil; however, influenza virus strains 
from this region and period are under investigation to 
confirm whether more H1N2v subtype cases may have 
occurred. This report highlights the need for influenza 
surveillance in humans and animals, as well as in their 
interface, especially during influenza season when trans-
mission is high. To ensure early detection, surveillance 
should focus on geographic areas when influenza A virus-
es subtypes co-circulate and where human–animal contact 
is frequent.
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Table. Highest degree of gene identity of the influenza 
A/Parana/720/2015 (H1N2)v subtype strain identified from a 
patient in Brazil with other swine and human strains* 
Gene 
segment BLAST hits† % Identity 
PB2 A/swine/Brazil/185-11-7/2011(H1N2) 98 
A/San Diego/INS194/2009(H1N1) 98 
PB1 A/swine/Brazil/185-11-7/2011(H1N2) 99 
A/Singapore/GN285/2009(H1N1) 98 
PA A/swine/Brazil/185-11-7/2011(H1N2) 98 
A/Texas/67/2009(H1N1) 98 
HA A/swine/Brazil/185-11-7/2011(H1N2) 97 
A/New York/487/2003(H1N2) 95 
NP A/swine/Brazil/185-11-7/2011(H1N2) 99 
A/Tennessee/F1057c56/2010(H1N1) 98 
NA A/swine/Brazil/185-11-7/2011(H1N2) 97 
A/Malaysia/17392/1998(H3N2) 93 
M A/swine/Brazil/185-11-7/2011(H1N2) 99 
A/Mexico City/INER16/2009(H1N1) 99 
NS A/swine/Brazil/185-11-7/2011(H1N2) 98 
A/Singapore/TT454/2010(H1N1) 98 
*Sequence submitted to GISAID (http://platform.gisaid.org; submission no. 
EPI_ISL_223342). HA, hemagglutinin gene; M, matrix gene; NA, 
neuraminidase gene, NP, nucleoprotein gene; NS, nonstructural protein 
gene; PB2, polymerase basic 2 gene; PB1, polymerase basic gene; PA, 
polymerase acid gene. 
†Sequence with major identity on BLAST. 
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To investigate an outbreak of avian pox in psittacines in a 
conservation facility, we examined 94 birds of 10 psittacine 
species, including sick and healthy birds. We found psitta-
cine pox virus in 23 of 27 sick birds and 4 of 67 healthy 
birds. Further characterization is needed for these isolates.
Avian pox is caused by avipoxvirus. Infections occur worldwide in domestic and wild avian species (1), 
are suggested to be host family- or order-specific, and are 
modulated by habitat and ecologic niche (2). Avipoxviruses 
have been described in Brazilian Amazona spp. and Pio-
nus spp. parrots with severe diphtheritic upper digestive 
lesions, experimentally causing the formation of cutane-
ous lesions in chickens; chicken and parrot strains will not 
provide cross protection (3). The presumptive diagnosis, 
based on typical pocklike skin lesions of papular or nodular 
hyperplasic and hypertrophic skin foci or upper digestive 
diphtheritic form in severe cases (1), may be confirmed by 
detection of avipoxvirus DNA by PCR (4).
In June 2015, an outbreak of avian pox occurred 
among 10 species of native Brazilian psittacines (n = 94) 
maintained in a conservation facility. In addition to the 
typical pocklike nodular skin lesions, the psittacines had 
weight loss and reduced activity; 3 died. The outbreak 
lasted 3 months; remission of lesions occurred within ≈3 
weeks in each bird.
Skin scrapings were collected from the cutaneous le-
sions of affected birds (online Technical Appendix Fig-
ure 1, http://wwwnc.cdc.gov/EID/article/23/1/16-1133-
Techapp1.pdf), and conjunctiva and cloaca swabs were 
collected from all 94 psittacines showing cutaneous lesions 
(27 birds) or not (67 birds). Skin samples treated with an an-
tibacterial–antimycotic drug mixture (Gibco; Thermo Fish-
er Scientific, Waltham, MA, USA) were inoculated onto 
the chorioallantoic membrane (CAM) of 10-day-old spe-
cific pathogen–free chicken embryos and typical pocklike 
CAM lesions were obtained (online Technical Appendix 
Figure 2). Cutaneous samples and the CAM of inoculated 
154 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 23, No. 1, January 2017
RESEARCH LETTERS
